menu
    • menu

    Company profile for Valbiotis

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    VALBIOTIS is a Research & Development company committed to scientific innovation for preventing and combating metabolic diseases. Founded in 2014, VALBIOTIS has adopted an innovative approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of major metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ValbiotisFrance Flag
    Country
    Country
    France
    Address
    Address
    12F rue Paul VATINE 17180 Périgny
    Telephone
    Telephone
    +33 5 46 28 62 58
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.valbiotis.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/valbiotis/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/valbiotis

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Valbiotis Presents the Full Results of the Phase II/III REVERSE-IT Study
    Valbiotis Presents the Full Results of the Phase II/III REVERSE-IT Study

    11 Sep 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=782817&lang=en

    ACCESSWIRE
    11 Sep 2023
    Share Share
    Valbiotis Announces the Large Success of Phase II/III Study on TOTUM•63
    Valbiotis Announces the Large Success of Phase II/III Study on TOTUM•63

    22 May 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230522005409/en

    BUSINESSWIRE
    22 May 2023
    Share Share
    Valbiotis Publishes Its 2022 Annual Results
    Valbiotis Publishes Its 2022 Annual Results

    15 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230315005519/en

    BUSINESSWIRE
    15 Mar 2023
    Share Share
    Valbiotis Announces Positive Results in Bioavailability and Mode of Action TOTUM
    Valbiotis Announces Positive Results in Bioavailability and Mode of Action TOTUM

    30 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230130005310/en

    BUSINESSWIRE
    30 Jan 2023
    Share Share
    Valbiotis: a Pivotal Year in the Execution of Its Clinical & Commercial Strategy
    Valbiotis: a Pivotal Year in the Execution of Its Clinical & Commercial Strategy

    10 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230109005534/en

    BUSINESSWIRE
    10 Jan 2023
    Share Share
    Valbiotis Successfully Completes a Fundraise of 9.7 Million Euros
    Valbiotis Successfully Completes a Fundraise of 9.7 Million Euros

    09 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221108006291/en

    BUSINESSWIRE
    09 Nov 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search